
Embattled Venezuelan President Nicolas Maduro announced two of Cuba’s vaccine candidates would arrive in Venezuela in the first week of April.
“We will participate in phase three of their clinical trials heading to this vaccine's mass production," he said during a news conference on Sunday.
Maduro said 30,000 doses of Soberana 02 and 30,000 doses of Abdala will come into the country. Both vaccine candidates are in phase 3 clinical trials.
“I thank President Diaz Canel, the Cuban Public Health System, Army General Raúl Castro, and thank you for incorporating Venezuela in these trials; we're together creating the answers and solutions of our Caribbean Latin America," Maduro said.
On March 4, Sacha Llorenti the executive director of ALBA-TCP (Bolivarian Alliance for the Peoples of Our America – Peoples' Trade Treaty), a regional bloc of left leaning Caribbean and Latin American countries, announced the creation of a vaccine bank for its member countries. Cuba and Venezuela are both members of ALBA and the delivery of the vaccines will take place through the organization according to Cuban state media.
The vaccine bank is for member states to use if they are in need and vaccines developed in Cuba will have priority to be part of the bank.